Thalidomide-piperidine-C-Pip-C2-Pip-C2-OH

Compound C6 is a thalidomide-piperidine conjugate designed as a key component for synthesizing PROTAC PARP1 degrader-30. This bifunctional molecule links a target-binding ligand to an E3 ligase recruiter, enabling the study of targeted protein degradation in cancer research models, both in vitro and in vivo.